Xtl Biopharmaceuticals Stock Forecast

Buy or Hold candidate since Jul 02, 2026 Gain 6.67%

The XTL Biopharmaceuticals Ltd. stock price fell by -1.03% on the last day (Monday, 13th Jul 2026) from $2.91 to $2.88. During the last trading day the stock fluctuated 5.45% from a day low at $2.75 to a day high of $2.90. The price has fallen in 5 of the last 10 days but is still up by 22.03% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -10 thousand shares and in total, 6 thousand shares were bought and sold for approximately $16.06 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -3.22% during the next 3 months and, with a 90% probability hold a price between $1.95 and $3.68 at the end of this 3-month period.

XTLB Signals & Forecast

The XTL Biopharmaceuticals Ltd. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $2.91. On a fall, the stock will find some support from the long-term average at approximately $2.52. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, July 06, 2026, and so far it has fallen -8.28%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for XTL Biopharmaceuticals Ltd. stock

On the downside, the stock finds support just below today's level from accumulated volume at $2.73 and $2.61. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, XTL Biopharmaceuticals Ltd. finds support just below today's level at $2.73. If this is broken, then the next support from accumulated volume will be at $2.61 and $2.49.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.150 between high and low, or 5.45%. For the last week the stock has had daily average volatility of 8.44%.

Our recommended stop-loss: $2.71 (-5.92%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 5 days ago.)

Trading Expectations (XTLB) For The Upcoming Trading Day Of Tuesday 14th

For the upcoming trading day on Tuesday, 14th we expect XTL Biopharmaceuticals Ltd. to open at $2.84, and during the day (based on 14 day Average True Range), to move between $2.73 and $3.03, which gives a possible trading interval of +/-$0.304 (+/-11.13%) up or down from last closing price. If XTL Biopharmaceuticals Ltd. takes out the full calculated possible swing range there will be an estimated 11.13% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.73 (5.21%) than the resistance at $3.14 (9.03%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is XTL Biopharmaceuticals Ltd. stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 2.260 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 14, 2026 - $2.84 ( 1.27%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk